Navigation Links
Aubrey Inc. Releases New Advanced Biosynthetic Wound Care Product 'AWBAT Plus'
Date:1/20/2011

CARLSBAD, Calif., Jan. 20, 2011 /PRNewswire/ -- Aubrey Inc. – http://www.aubreyinc.com – announced that after a successful soft release and product evaluation phase of its second generation product, AWBAT® Plus, it is now in full production and currently available for purchase.  Founder Aubrey Woodroof, PhD MBA, expresses his appreciation for being able to advance the art once again.  "It is a wonderful feeling to hear from a renowned surgeon that 'AWBAT® Plus has the potential to take wound coverage to the next level' and that it 'provides not only an optimal milieu but also a stimulus to promote active wound healing.'"

AWBAT® Plus utilizes the same patented technology for the precision-porous silicone-nylon membrane as the platform product, AWBAT®.  AWBAT® Plus, however, contains not only significantly more collagen but also chondroitin-4-sulfate, chondroitin-6-sulfate, vitamin C, vitamin E and Immuno-10 (activated mixture of polysaccharides from Aloe).  It was determined by FDA to be a combination product consisting of device components as well as drugs.  In subsequent laboratory testing, Immuno-10 was found to stimulate human dermal fibroblast proliferation, as well as fibroblast collagen and alpha-SMA production.  Human keratinocyte production was also enhanced by Immuno-10.  AWBAT® Plus is currently indicated for partial thickness burns, meshed autografts, and donor sites.

Woodroof stated: "We are very excited to have AWBAT® Plus now also available in our proprietary glove design.  Hand burns are common injuries and complex wounds to treat. The AWBAT® Plus Glove was designed specifically for ease of application and form fit, and to promote early mobility and rehabilitation, which is essential for maintaining functional dexterity and faster return to work."

Aubrey Inc. intends to seek clearance for use of AWBAT® Plus on chronic wounds this year.  Woodroof noted that in an investigator initiated evaluation of AWBAT® Plus on chronic wounds, the surgeon stated, "We have found AWBAT®-D Plus to be an effective alternative to Apligraf®, Dermagraft® and Integra® in preliminary observations of chronic wound management.  AWBAT®-D Plus can be used as an adjunct with NPWT."

About Aubrey Inc.

Dr. Aubrey Woodroof invented Biobrane® in 1978, an innovative product which revolutionized burn care.  In 2007, Woodroof came out of retirement to create the AWBAT® line as the next generation of advanced wound care technology.


'/>"/>
SOURCE Aubrey Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
2. CEL-SCI Corporation Releases Letter to Shareholders
3. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
4. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
5. Immunosyn Corporation Releases SF-1019 Study Results
6. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
7. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
8. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
9. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
10. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
11. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
Breaking Medicine News(10 mins):